Mode
Text Size
Log in / Sign up
Phase 3 N=1,635 Randomized Single-blind Prevention

The LIFE Study - Lifestyle Interventions and Independence for Elders

Sedentary Lifestyle · Risk of Disability · Aging

Enrolled (actual)
1,635
Serious AEs
47.5%
Results posted
Apr 2016
Primary outcome: Primary: Major Mobility Disability, Defined as Incapacity to Walk 400 Meters — 246; 290 participants — p=0.03

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Physical Activity (Behavioral); Successful Aging (Behavioral)
Age
Older Adult · 70+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Major Mobility Disability, Defined as Incapacity to Walk 400 Meters
246; 290 0.03 sig
SECONDARY
Persistent Mobility Disability (Assessed Every 6 Months)
120; 162 0.006 sig

Summary

Based upon promising results from a pilot study among 424 sedentary older adults who were randomized to a physical activity intervention or a successful aging health education intervention, a Phase 3 multi-center randomized controlled trial is being conducted to compare a moderate-intensity physical activity program to a successful aging health education program in 1,600 sedentary older adults who are followed for an average of 2.7 years. The primary aim was to assess the long-term effects of the proposed interventions on the primary outcome of major mobility disability, defined as inability to walk 400 m.

Eligibility Criteria

Inclusion Criteria

  • age 70 to 89 years; (2) summary score 200 mmHg and/or diastolic blood pressure > 110 mmHg).
  • Uncontrolled diabetes with recent weight loss, diabetic coma or frequent insulin reactions.
  • Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months.
  • Serious conduction disorder (e.g., 3rd degree heart block), uncontrolled arrhythmia, or new Q waves or ST-segment depressions (>3 mm) on ECG.
  • Myocardial infarction, major heart surgery (i.e., valve replacement or bypass surgery), stroke, deep vein thrombosis or pulmonary embolus in the past 6 months.
  • Undergoing physical therapy or cardiopulmonary rehabilitation
  • Currently enrolled in another randomized trial involving lifestyle or pharmaceutical interventions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01072500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search